Schrodinger(SDGR) - 2021 Q4 - Earnings Call Presentation
Schrodinger(SDGR)2022-02-28 01:17
Transforming Discovery of Therapeutics and Materials February 24, 2022 Fourth Quarter and Full-Year 2021 Supplemental Slides Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advant ...